Containment and response strategies for mpox outbreaks: a systematic review. [PDF]
Omam LA +4 more
europepmc +1 more source
Primary human intestinal organoids model enteric infection of monkeypox virus and enable scalable drug discovery. [PDF]
Li P +17 more
europepmc +1 more source
Combination of Mpox With Ocular Involvement, Human Immunodeficiency Virus, and Pulmonary Tuberculosis Resulting in High Mortality: A Report of Two Cases. [PDF]
Aziza Y, Simanjuntak GAM, Edwar L.
europepmc +1 more source
Tecovirimat is active against various MPXV strains, while cidofovir, brincidofovir, trifluridine, and gemcitabine have no detectable MPXV-specific antiviral activity. [PDF]
Higashi-Kuwata N +4 more
europepmc +1 more source
Novel 2-Aryl-1H-Benzimidazole Derivatives and Their Aza-Analogues as Promising Anti-Poxvirus Agents. [PDF]
Manca V +14 more
europepmc +1 more source
The impact of human immunodeficiency virus coinfection on mpox patients during the 2022 global outbreak: a systematic review and meta-analysis based on comparative observational studies. [PDF]
Han Y, Li X, Wang X, Zhong Z.
europepmc +1 more source
Myocarditis and Pericarditis as a Complication of Mpox: Case Series and Literature Review. [PDF]
Halani S +13 more
europepmc +1 more source
Monkeypox (Mpox), a Resurging Global Public Health Concern: An Updated Outlook Through 2025. [PDF]
Islam DZ +13 more
europepmc +1 more source
Mpox: What Have We Learned and How Do We Better Prepare for the Future? [PDF]
Judson SD, Orkin CM, Gebo K.
europepmc +1 more source

